Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Nucleoside Metabolic Inhibitor Drug Class List

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drugs in Drug Class: Nucleoside Metabolic Inhibitor

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis ARRANON nelarabine INJECTABLE;INTRAVENOUS 021877-001 Oct 28, 2005 RX Yes Yes   Start Trial   Start Trial   Start Trial
Shilpa Medicare AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 207518-001 Sep 29, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 201537-001 Sep 16, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
Natco Pharma Ltd AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 207234-001 Jun 23, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Actavis Llc AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 208216-001 Apr 29, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.